ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: SA-PO420

The Effect of Hemodiafiltration vs. High-Flux Dialysis on Middle- and Large-Sized Molecules' Reduction and Its Relation to Albumin Loss Using Big Surface-Area Dialyzer 2.6 m2

Session Information

Category: Dialysis

  • 701 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Elsayed, Hesham Mohamed, Ain Shams University Faculty of Medicine, Cairo, Egypt
  • ElSharkawy, Magdy, Ain Shams University Faculty of Medicine, Cairo, Egypt
  • Aref, Hayam M., Ain Shams University Faculty of Medicine, Cairo, Egypt
  • Abdelmohsen, Waleed Anwar, Ain Shams University Faculty of Medicine, Cairo, Egypt
  • Khedr, Abdelrahman Nabil, Ain Shams University Faculty of Medicine, Cairo, Egypt
  • Abdallah, Hussein Sayed Hussein, Ain Shams University Faculty of Medicine, Cairo, Egypt
  • Abdallah, Shaimaa Zaki abdelmegied, Ain Shams University Faculty of Medicine, Cairo, Egypt
  • Sultan, Reem Ahmed, Ain Shams University Faculty of Medicine, Cairo, Egypt
  • Radwan, Mohamed Fathy, Ain Shams University Faculty of Medicine, Cairo, Egypt
  • Magdi, Aya Mohamed, Ain Shams University Faculty of Medicine, Cairo, Egypt
  • Abdelwahab, Khaled Gouda, Ain Shams University Faculty of Medicine, Cairo, Egypt
  • Elbraky, Abdelrahman Ali, Ain Shams University Faculty of Medicine, Cairo, Egypt
  • Emara, Ahmed, Ain Shams University Faculty of Medicine, Cairo, Egypt
Background

Uremic toxins are classified into small, middle-sized, and protein-bound solutes. Removal of middle-sized molecules with minimal albumin loss is needed. This study assessed different molecules’ removal using 2.6m2 surface area (SA) dialyzer on high-flux haemodialysis (HF-HD) vs. hemodiafiltration (HDF) and its relation to albumin loss

Methods

A crossover study included 25 patients, underwent HF-HD followed by online post-dilution HDF using dialyzer; BIOPURE (Biorema) 260 HF (with a SA 2.6 m2, High-flux hollow Fiber Hemodialysis membrane with steam sterilization, myoglobin SC 0.7, membrane cutoff value 40 KDa.), with 2-weeks washout period. All patients were subjected to single session assessment of cumulative dialysate albumin loss, and to measurement of pre-post dialysis Reduction values of Kappa and Lambda free light chains (FLC), α-1-microglobulin (MG), IL-6 and procalcitonin by ELISA.

Results

There was significant reduction in post-dialysis levels of all molecules in HF-HD and HDF compared to pre-dialysis levels (P<0.001). HDF showed higher post dialysis reduction ratio of kappa and lambda FLC, α 1-MG, IL-6 and procalcitonin (P<0.001). Total dialysate albumin loss on HDF was higher compared to HF-HD with median of 2.46 (1.7 – 2.8 IQR), 0.65 (0.48 – 1.1 IQR) respectively. Maximum albumin loss on HDF was in the first hour with a median of 1.20 (0.77 – 1.3 IQR). Transmembrane pressure was positively correlated with total albumin loss in both modalities.

Conclusion

BIOPURE (Biorema) 260 HF, 2.6 m2 SA, may be effective in medium-sized molecules’ removal especially with online post-dilution HDF with acceptable albumin loss

RR% of different molecules in HD vs HDF

Funding

  • Private Foundation Support